Latest News about INCY
Recent news which mentions INCY
FDA Approves Incyte/Syndax Partnered Drug For Chronic Graft-Versus-Host Disease, A Post-Transplant Complication
August 15, 2024
From Benzinga
After Reporting Five Patient Deaths, Data Committee Recommends MacroGenics Halt Prostate Cancer Trial
July 31, 2024
From Benzinga
Incyte's Q2 Earnings: Wider Than Expected Loss, Pipeline Review, Lifts Jakafi Sales Guidance
July 30, 2024
From Benzinga
From Benzinga
From InvestorPlace
7 Cheap Biotech Stocks With Major Upside Potential
July 09, 2024
From InvestorPlace
3 Highly Rated Biotech Stocks for Your July Buy List
July 05, 2024
From InvestorPlace
From Benzinga
7 Undervalued Biotech Stocks to Buy for Big-Time Returns
July 01, 2024
From InvestorPlace
Nasdaq 100, S&P 500 Close At Record Highs As Tech Stocks Reclaim Dominance: Thursday's Gainers & Losers
June 13, 2024
From Benzinga
10 Health Care Stocks Whale Activity In Today's Session
June 04, 2024
From Benzinga
Hedge Funds Tweak Portfolios In Q1: Marvell, TD Synnex, AES Get More Love As Focus Shifts To AI
May 24, 2024
From Benzinga
From Benzinga
From Benzinga
The 3 Best Biotech Stocks to Buy in May 2024
May 09, 2024
From InvestorPlace
Tickers
INCY
From InvestorPlace
Incyte Should Consider Significant Stock Buyback And Prioritize R&D, Analyst Recommends
April 23, 2024
From Benzinga
From InvestorPlace
From InvestorPlace
7 Under-the-Radar Biotech Stocks Gearing Up for Liftoff
February 26, 2024
From InvestorPlace
Exit Now! 3 Biotech Stocks to Sell in February 2024
February 21, 2024
From InvestorPlace
Earnings Scheduled For February 13, 2024
February 13, 2024
From Benzinga